Examination of IL-1β level as an inflammasome marker in Alzheimer's disease
Main Authors: | Onur Bulut, Anıl Tanburoğlu, Gülşah Bölük, Nurhak Demir, Erden Eren, Ufuk Vurgun, Şermin Genç, Görsev Yener |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-09-01
|
Series: | Neurological Sciences and Neurophysiology |
Online Access: | https://nsnjournal.org/eng/makale/1149/152/Full-Text |
Similar Items
-
Follow-up Analysis of Serum TNF-Related Apoptosis-Inducing Ligand Protein and mRNA Expression in Peripheral Blood Mononuclear Cells from Patients with Ischemic Stroke
by: Kemal Ugur Tufekci, et al.
Published: (2018-03-01) -
Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders
by: Bora Tastan, et al.
Published: (2022-03-01) -
The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases
by: Burak Ibrahim Arioz, et al.
Published: (2021-06-01) -
Delay of cognitive gamma responses in Alzheimer's disease
by: Erol Başar, et al.
Published: (2016-01-01) -
Investigation of the Factors Affecting Quality of Life in Patients with Mild to Moderate Alzheimer’s Disease in Terms of Patients and Caregivers
by: Elvan Felekoğlu, et al.
Published: (2021-10-01)